425 related articles for article (PubMed ID: 24894866)
1. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.
Singh B; Chatterjee A; Ronghe AM; Bhat NK; Bhat HK
BMC Cancer; 2013 May; 13():253. PubMed ID: 23697596
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.
Singh B; Bhat HK
Carcinogenesis; 2012 Dec; 33(12):2601-10. PubMed ID: 23027624
[TBL] [Abstract][Full Text] [Related]
5. Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells.
Yang L; Zahid M; Liao Y; Rogan EG; Cavalieri EL; Davidson NE; Yager JD; Visvanathan K; Groopman JD; Kensler TW
Carcinogenesis; 2013 Nov; 34(11):2587-92. PubMed ID: 23843041
[TBL] [Abstract][Full Text] [Related]
6. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.
Smolarek AK; So JY; Thomas PE; Lee HJ; Paul S; Dombrowski A; Wang CX; Saw CL; Khor TO; Kong AN; Reuhl K; Lee MJ; Yang CS; Suh N
Mol Carcinog; 2013 Jul; 52(7):514-25. PubMed ID: 22389237
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
8. Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.
Singh B; Bhat NK; Bhat HK
Carcinogenesis; 2012 Jan; 33(1):156-63. PubMed ID: 22072621
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.
Zhou X; Zhao Y; Wang J; Wang X; Chen C; Yin D; Zhao F; Yin J; Guo M; Zhang L; Du L; Zhang B; Yin X
Biochem Pharmacol; 2018 Sep; 155():252-263. PubMed ID: 30009768
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway.
He X; Wang L; Szklarz G; Bi Y; Ma Q
J Pharmacol Exp Ther; 2012 Jul; 342(1):81-90. PubMed ID: 22493042
[TBL] [Abstract][Full Text] [Related]
11. Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis.
Das Gupta S; Patel M; Wahler J; Bak MJ; Wall B; Lee MJ; Lin Y; Shih WJ; Cai L; Yang CS; Suh N
Cancer Prev Res (Phila); 2017 Dec; 10(12):694-703. PubMed ID: 28972008
[TBL] [Abstract][Full Text] [Related]
12. Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesis.
Chatterjee A; Ronghe A; Singh B; Bhat NK; Chen J; Bhat HK
J Biochem Mol Toxicol; 2014 Dec; 28(12):529-38. PubMed ID: 25130429
[TBL] [Abstract][Full Text] [Related]
13. Lung endothelial barrier protection by resveratrol involves inhibition of HMGB1 release and HMGB1-induced mitochondrial oxidative damage via an Nrf2-dependent mechanism.
Dong WW; Liu YJ; Lv Z; Mao YF; Wang YW; Zhu XY; Jiang L
Free Radic Biol Med; 2015 Nov; 88(Pt B):404-416. PubMed ID: 25979658
[TBL] [Abstract][Full Text] [Related]
14. Allyl isothiocyanate, a potent chemopreventive agent targets AhR/Nrf2 signaling pathway in chemically induced mammary carcinogenesis.
Rajakumar T; Pugalendhi P; Thilagavathi S; Ananthakrishnan D; Gunasekaran K
Mol Cell Biochem; 2018 Jan; 437(1-2):1-12. PubMed ID: 28585088
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
Yager JD
Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108
[TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways.
Mandal A; Bhatia D; Bishayee A
Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452959
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
Mense SM; Singh B; Remotti F; Liu X; Bhat HK
Carcinogenesis; 2009 Jul; 30(7):1202-8. PubMed ID: 19406931
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN
Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951
[TBL] [Abstract][Full Text] [Related]
19. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Banerjee S; Bueso-Ramos C; Aggarwal BB
Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.
Chen ZH; Hurh YJ; Na HK; Kim JH; Chun YJ; Kim DH; Kang KS; Cho MH; Surh YJ
Carcinogenesis; 2004 Oct; 25(10):2005-13. PubMed ID: 15142886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
